Delivery Order SPE2DB22D3301-SPE2DB24FY7NE
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The total ceiling value of the contract is $1,251.23 and the ultimate completion date is June 5, 2025. This is an unrestricted contract with no set-aside designation. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4565978297 GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML. The contract has a ceiling value of $1,398.76 and an ultimate completion date of October 1, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of 4563709638 GLYCOPYRROLATE 0.2 MG/ML VIAL 20ML, with a ceiling value of $7,133.90 and an ultimate completion date of February 21, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor registered in the System for Award Management (SAM.gov) since 2002, and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568810915 - GLYCOPYRROLATE 1 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,699.42 and a completion date of July 17, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,773.33, is for the delivery of 0.2 mg/mL vials of the medication glycopyrrolate. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564090046 - Glycopyrrolate 0.2 mg/ml Vial/ml. The contract has a ceiling value of $7,016.45 and a period of performance through March 28, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of 4,564,054,166 units of the drug glycopyrrolate 0.2 mg/ml in 20 ml vials, with a ceiling value of $1,576.96 and a performance period through March 25, 2024. This delivery order is issued under a larger indefinite delivery contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of glycopyrrolate 0.2 mg/ml vials, a pharmaceutical product used in medical treatment programs. The contract has a ceiling value of $1,541.27 and a period of performance through March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,021.25 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for the purchase of 4563575117...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY7NEDelivery Order
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medical product, with a ceiling value of $7,484.43 and a period of performance through May 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/29/24 |